Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on October 11th, 2017 by Christy J. Wilson in Pharma R&D
Researchers are always looking for new ways to attack cancer, and the scientists at Boston-based biotech start-up Rubius Therapeutics have happened upon an unexpected ally: the red blood cell.
Posted on September 6th, 2017 by Dr Andrew A. Parsons in Pharma R&D
Opinions matter; they can drive our behaviors. Within the context of Pharma R&D, it is important to harness the benefits of different views, to think outside the box, innovate and beat the safety of group thinking.
Posted on August 23rd, 2017 by Christine de Vries - Scheidegger in Pharma R&D
R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. (more…)
Posted on July 17th, 2017 by Dr Andrew A. Parsons in Pharma R&D
The recent election results in France and the UK once again show that a week is a long time in politics. Who would have thought when the UK voted to Brexit that Emmanuel Macron would sweep into power following the creation of his new political party in April 2016? (more…)